The Food and Drug Administration aims to lower nicotine in cigarettes

Barsaba Taglieri
Luglio 30, 2017

"We think today's announcement is an important evolution in the Agency's approach to regulating tobacco products and a meaningful step forward in developing a comprehensive regulatory policy that acknowledges the continuum of risk". Tobacco use is the leading cause of preventable heart disease, cancer and death in the United States, causing more than 480,000 deaths annually.

Gottlieb also gave a four year time to companies that produce e-cigarettes to review their products and also cut nicotine levels. Smoking rates, though, have been falling for decades and are at about 15 percent.

The FDA, however, cannot reduce the nicotine levels in cigarettes to zero, it cannot ban cigarette production either.

Nicotine is not necessarily deadly but it's addictive and a cigarette has also other substances and tar in it which through smoking they are a danger to smokers' health.

The good news is that over the years, smoking has lowered. There have been concerns that smokers might react to lower nicotine levels by smoking more. "Most of the harm associated with smoking is related not to the nicotine but everything else in the smoke".

Cigarette manufacturers could soon be forced to make their products less addictive.

Another research studies whether the smokers who turn on lower nicotine cigarettes will choose to start using e-cigarettes or other products that are not as harmful as cigarettes. Kenneth Warner, a retired University of MI public health professor who is a leading authority on smoking and health, said he was pleasantly surprised to learn of the FDA announcement. "This long delay will allow egregious, kid-friendly e-cigarettes and cigars, in flavors like gummy bear, cherry crush and banana smash, to stay on the market with little public health oversight", Myers said in a statement.

Altria Group, the company which sells cigarettes in the U.S, such as Marlboro and even e-cigarettes, stated that it will follow the FDA rules and that if the department will base their decision on science and evidence, then they will go along as long as it is achievable from a technical point of view.

Altre relazioni OverNewsmagazine

Discuti questo articolo

SEGUI I NOSTRI GIORNALE